Evidence map›Paper›PMID 30879104›Full record

ArticleCurrent microbiology2019

Phylogenetic Studies on the Prodigiosin Biosynthetic Operon.

Aarti Ravindran, Shruthi Sunderrajan, Gautam Pennathur

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Enhanced Prodigiosin Production inApplied and environmental microbiology · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Aarti RavindranCentre for Biotechnology, Anna University, Chennai, Tamil Nadu, 600 025, India.ORCID http://orcid.org/0000-0001-7558-4627
Shruthi SunderrajanDepartment of Chemical Engineering, Anna University, Chennai, Tamil Nadu, 600 025, India.ORCID http://orcid.org/0000-0002-9390-3836
Gautam PennathurCentre for Biotechnology, Anna University, Chennai, Tamil Nadu, 600 025, India. gpennathur@gmail.com.ORCID http://orcid.org/0000-0003-3140-3796
Anna University, Chennai · IN

Funding

Council of Scientific and Industrial Research 09/468/(0486)/2014-EMR-1Department of Biotechnology, Ministry of Science and Technology BT/PR5106/BRB/10/1073/2012
6 · The paper itself

Abstract

Prodigiosin and undecylprodigiosin are tripyrrolic red pigmented antibiotics produced by certain bacteria. Many strains of Serratia and certain other Gammaproteobacteria produce prodigiosin and undecylprodigiosin is produced by certain strains of Streptomyces. This is a multistage process which involves the synthesis of a bipyrrolic compound from L-proline and its subsequent condensation with a mono pyrrole synthesized from 2-octenal in the case of prodigiosin and malonyl-CoA in the case of undecylprodigiosin respectively. We have carried out sequence analysis of the genes involved in the pathway and identified the distribution of the prodigiosin producing genes amongst the various bacteria which have been fully sequenced. The presence of the operon was clearly seen in certain clustered branches suggesting inheritance from a common ancestor. This was further confirmed by the absence of traits observed in horizontally acquired genes like, GC content variation, codon bias or the presence of mobile elements. Multiple sequence alignment of the promoter of the prodigiosin operon in seven fully sequenced Serratia marcescens strains showed excellent homology. Putative regulatory elements in this region were identified by sequence analysis studies and many of them have been found to influence pigment production. The undecylprodigiosin gene cluster on the other hand, shows homology to other gene clusters involved in the production of other pyrrole-containing antibiotics of the genus Streptomyces. This coupled with the presence of ORFs with three different promoters could indicate lateral gene transfer. Hence the evolution of undecylprodigiosin operon could be an example of convergent evolution.

Indexed as

Evolution, MolecularOperonPhylogenyAnti-Bacterial AgentsBacterial ProteinsBiosynthetic PathwaysMultigene FamilyProdigiosinPromoter Regions, GeneticSequence Analysis, DNASerratiaSerratia marcescensStreptomycesAnti-Bacterial AgentsBacterial ProteinsProdigiosinundecylprodigiosin

Identifiers

PMID30879104
OpenAlexW2921353785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.